tiprankstipranks
Cara Therapeutics (CARA)
NASDAQ:CARA

Cara Therapeutics (CARA) Stock Investors

2,235 Followers
Based on 746,803 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CARA
On average, investors allocate 2.49% of their portfolios to CARA
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 746,803 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CARA

1.7%
Last 7
Days
5.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CARA, out of 746,803 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CARA Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,174 investors who made their portfolios public
The table shows changes in CARA in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CARA Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.86%
-1.32%
-1.44%
34.65B
Consumer Cyclical
Bristol-Myers Squibb
3.16%
-0.30%
+2.10%
81.39B
Healthcare
Block
4.26%
-0.55%
+0.72%
44.46B
Technology
GE Aerospace
5.17%
-0.80%
+1.03%
174.66B
Industrials
Merck & Company
3.90%
+0.27%
+4.31%
324.50B
Healthcare
Applied Materials
4.70%
+0.22%
+6.34%
203.31B
Technology
ChargePoint Holdings
4.22%
-1.16%
-2.22%
927.16M
Consumer Cyclical
Delta Air Lines
5.17%
-0.52%
+2.71%
27.75B
Industrials
Baidu
5.24%
+1.79%
+13.83%
34.93B
Communication Services
Plug Power
5.06%
-1.00%
-2.55%
2.38B
Industrials
Based on the activity of 746,803 active portfolios
Open your Smart Portfolio

CARA Investor Analysis

CARA investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
8.5%
of CARA holders
are under 35
Average Segment Performance
Average P/E Ratio21.96
Beta7.16
Dividend Yield6.43%
CARA investors between 35–55

Between 35–55

3.0%
Last 30 days
Holdings Change
40.3%
of CARA holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.75
Beta11.80
Dividend Yield6.41%
CARA investors over 55

Over 55

3.3%
Last 30 days
Holdings Change
51.2%
of CARA holders
are over 55
Average Segment Performance
Average P/E Ratio20.82
Beta3.95
Dividend Yield7.83%
Overview of age group and performance of CARA stock investors
See who invests in CARA according to age group and performance.

FAQ

How many retail Investors hold CARA?
<0.1% of TipRanks' retail investors hold CARA in their portfolios.
    What is CARA Investor Sentiment?
    CARA’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CARA in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of CARA in the last 7 days.
        What percentage of retail investors changed their holding of CARA in the last 30 days?
        ▼ 5.2% of TipRanks' retail investors changed their holding of CARA in the last 30 days.
          What is the average age of retail investors who hold CARA?
          The average age of CARA Holders is over 55.
            What other stocks have CARA investors also bought?
            CARA Investors also bought DKNG, BMY, SQ, GE, MRK, AMAT, CHPT, DAL, BIDU, PLUG.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BCRXBioCryst
              BSXBoston Scientific
              CYTKCytokinetics
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis